New diabetes clinical trial: Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells

Published on: August 20, 2019 at 07:00PM
Condition:   Diabetes Mellitus, Type 1
Interventions:   Biological: Mesenchymal Stem Cells (MSCs);   Other: Placebo Infusion (Plasmalyte A with 0.5% human serum albumin)
Sponsors:   Medical University of South Carolina;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting